The molecular basis of cystic fibrosis in South Africa

Clinical Genetics

Volumn 59, Issue 1, 2001, Pages 37-41

  Goldman, A ^a,d   Labrum, R ^a,b   Claustres, M ^a   Desgeorges, M ^a   Guittard, C ^c   Wallace, A ^a   Ramsay, M ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Institut de Biologie   (France)

^c ST MARY S HOSPITAL   (United Kingdom)

^d Department of Human Genetics ^*  (South Africa)

Author keywords

African populations; CFTR mutations; Cystic fibrosis; Haplotypeanalysis

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CAUCASIAN; CHROMOSOME; CYSTIC FIBROSIS; EUROPE; FOUNDER EFFECT; GENE MUTATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MUTATION RATE; NEGRO; PRIORITY JOURNAL; SOUTH AFRICA;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; EPIDEMIOLOGY, MOLECULAR; GENE FREQUENCY; HAPLOTYPES; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SOUTH AFRICA;

EID: 0035169491     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2001.590106.x     Document Type: Article

References (26)

1. Cystic fibrosis in Cape Town
2. Cystic fibrosis carrier frequencies in populations of African origin
3. Frequency of the ΔF508 mutation in South African families with cystic fibrosis
4. Analysis of 40 known cystic fibrosis mutations in South African patients
5. The frequency of the ΔF508 mutation in the cystic fibrosis gene of 71 unrelated South African cystic fibrosis patients
6. A simple salting out procedure for extracting DNA from human nucleated cells
7. First report of CFTR mutations in black cystic fibrosis patients of Southern Africa
8. Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene
9. Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene
10. Multiplex PCR amplification of three microsatellites within the CFTR gene
11. Prenatal diagnosis of cystic fibrosis by DNA amplification for the detection of KM-19 polymorphism
12. Transcript analysis of CFTR frameshift mutations in lymphocytes using the reverse transcription polymerase chain reaction technique and the protein truncation test
13. Cystic fibrosis patients with the 3272 - 26A → G mutation have mild disease, leaky alternative mRNA splicing and CFTR protein at the cell membrane
14. Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions
15. CFTR haplotype backgrounds on normal and mutant CFTR genes
16. Analysis of the 27 exons and flanking regions of the cystic fibrosis gene, 40 different mutations account for 91.2% of the mutant alleles in Southern France
17. 394delTT-a Nordic Cystic fibrosis mutation
18. Cystic fibrosis in a low incidence population: 2 major mutations in Finland
19. Analysis of 22 cystic fibrosis mutations in 62 Patients from the Flanders, Belgium, reveals a high prevalence of the Nordic mutation 394delTT
20. The identification of a novel CFTR mutation: 3120 + 1G → A
21. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%
22. Characterization of more than 85% of cystic fibrosis alleles in the Greek population, including five novel mutations
23. Novel and characteristic CFTR mutations in Saudi Arab children with severe Cystic Fibrosis
24. Evidence for a common ethnic orgin of cystic fibrosis mutation 3120 + 1G → A in diverse populations
25. The diagnosis of cystic fibrosis, a consensus statement